ABI Targets Low End of Research Market With Launch of New RT-PCR Instrument | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Applied Biosystems is gearing up to launch a new real-time PCR instrument intended to capture the low end of the research market through a smaller price tag and enhanced ease of use.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.